Methylphenidate Hydrochloride Tablet, Extended Release
Product Images NDC 62175-313

8 FDA label images from Lannett Company, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Methylphenidate Hydrochloride (NDC 62175-313). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lannett Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Methylphenidate Hydrochloride Extended Release Tab 1)

Chemical Structure (Methylphenidate Hydrochloride Extended Release Tab 1)
Chemical structure diagram of Methylphenidate Hydrochloride, showing the molecular arrangement including a phenyl group, methyl ester, and a piperidine ring with an HCl salt.*
FDA Label Image

Figure 1 (Methylphenidate Hydrochloride Extended Release Tab 2)

Figure 1 (Methylphenidate Hydrochloride Extended Release Tab 2)
Pharmacokinetic line graph comparing mean plasma methylphenidate concentrations (ng/mL) over time (hours) for Methylphenidate HCl 18 mg once daily versus Methylphenidate 5 mg taken three times daily. The x-axis represents time up to 32 hours, and the y-axis shows methylphenidate concentration up to 5 ng/mL.*
FDA Label Image

Figure 2 (Methylphenidate Hydrochloride Extended Release Tab 3)

Figure 2 (Methylphenidate Hydrochloride Extended Release Tab 3)
A bar chart comparing the Inattention/Overactivity Scale scores between Methylphenidate HCl once daily and placebo groups across three studies with varying dosages (5-15 mg, 20 mg, 10-15 mg). The vertical axis represents the scale scores, highlighting the difference in symptoms between treatment and placebo groups.*
FDA Label Image

Figure 3 (Methylphenidate Hydrochloride Extended Release Tab 4)

Figure 3 (Methylphenidate Hydrochloride Extended Release Tab 4)
A line graph comparing the combined attention subscale scores over 12 hours between patients treated with once-daily Methylphenidate Hydrochloride and those given a placebo. The vertical axis ranges from more attentive to less attentive, while the horizontal axis shows hours post initial dose, with mean and standard error indicated by data points and error bars.*
FDA Label Image

18 mg 100 Count (Methylphenidate Hydrochloride Extended Release Tab 5)

18 mg 100 Count (Methylphenidate Hydrochloride Extended Release Tab 5)
Label for Methylphenidate Hydrochloride Extended-Release Tablets, USP 18 mg, manufactured by Kremers Urban Pharmaceuticals Inc. The label indicates oral extended-release tablets supplied in a bottle of 100 tablets. Storage instructions specify to keep at 25°C (77°F) with permitted excursions and to protect from humidity. The label also includes dosage guidance to see the package insert and mentions the product is Rx only.*
FDA Label Image

27 mg 100 Count (Methylphenidate Hydrochloride Extended Release Tab 6)

27 mg 100 Count (Methylphenidate Hydrochloride Extended Release Tab 6)
Label for Methylphenidate Hydrochloride Extended-Release Tablets USP 27 mg from Lannett Company, Inc. The label includes storage instructions, dosage form, and manufacturer details. It states each tablet contains 27 mg methylphenidate hydrochloride in a controlled-release formulation, with usual dosage once daily. Package contains 100 tablets.*
FDA Label Image

36 mg 100 Count (Methylphenidate Hydrochloride Extended Release Tab 7)

36 mg 100 Count (Methylphenidate Hydrochloride Extended Release Tab 7)
Methylphenidate HCl Extended-Release Tablets USP, 36 mg, dosage form is extended-release tablets for oral use. The label indicates it contains 100 tablets and is manufactured by Kremers Urban Pharmaceuticals Inc. Storage instructions include keeping the medication at 25°C (77°F) with permitted excursions, and protecting it from humidity. The label is marked Rx only with a barcode and the NDC 62175-312-37.*
FDA Label Image

54 mg 100 Count (Methylphenidate Hydrochloride Extended Release Tab 8)

54 mg 100 Count (Methylphenidate Hydrochloride Extended Release Tab 8)
Label for Methylphenidate Hydrochloride Extended-Release Tablets, USP 54 mg by Lannett Company, Inc. The label states each tablet contains 54 mg methylphenidate hydrochloride in a controlled-release formulation. It includes storage instructions and a note for pharmacists to dispense the accompanying Medication Guide. The package contains 100 tablets and is indicated for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.